Pamela Monterola

Pamela Monterola is a seasoned professional in regulatory and clinical affairs, currently serving as Senior Director at Outlook Therapeutics, Inc. since July 2023. With a robust background that includes roles such as Senior Director of Clinical and CMC Regulatory Affairs at Aceragen and Associate Director of CMC Regulatory Affairs at Viridian Therapeutics, Pamela has developed extensive expertise in project management and regulatory affairs. Previous positions also include Director of CMC Regulatory Affairs at Turning Point Therapeutics and Senior CMC Regulatory Science Specialist at Regeneron Pharmaceuticals. Pamela holds a Doctor of Philosophy in Chemistry from the University of Florida, obtained in January 2007.